Summary
We have evaluated the pharmacokinetics of high doses of clonidine, as used in the prophylactic treatment of alcohol withdrawal syndrome, in 11 alcohol-dependent patients undergoing surgery for oesophagogastrectomy.
Clonidine was given in a bolus of 150 μg followed by a continuous infusion. After a mean period of treatment of 9.2 (range 3 to 26) days and a mean dose of 0.72 (range 0.29 to 2.37) mg per day of clonidine the mean terminal half-life was 15.8 (range 9.9 to 23) h (n=7).
In order to compare initial and terminal half-lives of clonidine intraindividually, four patients were given a bolus of 150 μg followed 24 h later by a continuous infusion. The pharmacokinetics of clonidine were described by two exponentials, with a distribution half-life of 1.2 h and a terminal half-life of 14.6 h. After a mean period of 8.3 (range 2 to 15) days and a mean dose of 0.62 (range 0.15 to 1.82) mg per day the terminal half-life in these four patients was 15.6 (range 14.0 to 17.9) h. The relation between dosage and plasma concentration was linear.
Similar content being viewed by others
References
Baumgartner GR, Rowen RC (1987) Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 147: 1223–1226
Baumgartner GR, Rowen RC (1991) Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 84: 312–321
Bjokvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiatr Scand 52: 256–263
Wilkins AJ, Jenkins WJ, Steiner JA (1983) Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 81: 78–80
Hogan MJ, Wallin JD, Chu L-C (1981) Plasma clonidine concentration and pharmacologic effect. Clin Pharmacol Ther 12: 729–734
Verner Lj, Hartmann M, Seitz W (1990) Clonidinsupplementierte Analgosedierung zur postoperativen Delirprophylaxe. Anaesth Intensivther Notfallmed 25: 274–280
Palme M, Schäfer E, Lange S (1989) Clonidine bei der Behandlung des Delirium tremens klinische Erfahrungen. Anaesthesiol Intensivmed 30: 354–359
Arnts D, Stähle H, Förster HJ (1981) Development of a RIA for clonidine and its comparison with the reference methods. J Pharmacol Meth 3: 103–115
Anavekar SN, Howes LG, Jarrot B, Syrjanen M, Conway EL, Louis WJ (1989) Pharmacokinetics and antihypertensive effects of low dose clonidine during chronic therapy. J Clin Pharmacol 29: 321–326
MacGregor TR, Matzke KM, Keirns JJ, van Wayjen RGA, van Ende A (1985) Pharmacokinetics of transdermally delivered clonidine. Clin Pharmacol Ther 38: 278–284
Lowenthal DT, Matzke KM, MacGregor TR (1988) Clinical pharmacokinetics of clonidine. Clin Pharmacokinetics 14: 287–310
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fauler, J., Verner, L. The pharmacokinetics of clonidine in high dosage. Eur J Clin Pharmacol 45, 165–167 (1993). https://doi.org/10.1007/BF00315500
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315500